• 제목/요약/키워드: small renal cell carcinoma

검색결과 28건 처리시간 0.024초

대측 신장이 정상인 신종양 환자에서 신보존수술의 임상 경험 (Clinical Experience of Nephron Sparing Surgery for Renal Tumor with a Normal Opposite Kidney)

  • 이준영;김정현;이강민;문기학;정희창;박동춘
    • Journal of Yeungnam Medical Science
    • /
    • 제16권1호
    • /
    • pp.94-100
    • /
    • 1999
  • 본 연구는 신보존수술의 임상적 가치를 알아보기 위해, 반대측 신장이 기능적으로 정상인 작은 크기의 고형 신종양 환자를 대상으로 신보존수술을 이용한 환자의 임상 경과를 후향적인 조사를 통하여 알아보고자 하였다. 21례의 환자중 술전 방사선 영상 소견상 신세포암으로 추정된 15례의 환자는 술후 병리조직학적 검사 결과 14례에서 신세포암($T_1N_0M_0$ : 14례)으로, 1례에서 호산성과립세포종으로 진단되었다. 신혈관지방종으로 추정된 4례는 역시 신혈관지방종으로 진단되었고, 또한 신세포암과 구별하기 어려웠던 2례는 선혈관지방종 및 해면상혈관종으로 각각 밝혀졌다. 신세포암의 재발, 원격 전이 및 신세포암으로 인한 사망 등은 추척 관찰 기간(평균 18.6개월, 1-103개월) 중 관찰되지 않았고 양성 신종양 환자군에서도 종양의 재발은 관찰되지 않았다(평균 추척 관찰 기간 : 43.8개월, 7-97개월). 신보존수술의 합병증으로는 1례의 신세포암에서 wedge resection을 시행한 후 술후 10일에 신출혈로 인한 육안적 혈뇨 및 혈압 저하의 소견이 나타나 근치적 신적출술을 시행하였고, 그 외 다른 환자에서는 요낭종, 후복막혈종 및 폐 색전증 등과 갈은 합병증은 관찰되지 않았다. 이상의 결과에서, 대측 신장의 기능이 정상인 작은 표기(4cm 이하)의 단일 고형 신종양 환자일 경우 신기능을 보존하기 위하여 신보존수술은 좋은 치료법으로 생각되며 일차적인 치료법으로 사용되어도 유익하리라 기대되나, 향후 보다 장기적인 추적 관찰이 필요하리라 생각된다.

  • PDF

A Rare Case of Canine Huge Renal Cell Carcinoma with Ovarian Metastasis

  • Koo, Jiyoung;Song, Woo-Jin;Jo, Heesoo;Ahn, Hyerin;Choi, Solji;Jeong, Hyohoon;Cheong, Jongtae;Park, Hyun-Jung;Yun, Youngmin
    • 한국임상수의학회지
    • /
    • 제39권4호
    • /
    • pp.168-172
    • /
    • 2022
  • A 10-year-old female Pomeranian weighing 2.25 kg with a history of gradual weight loss and an intraabdominal mass confirmed with ultrasonography at a local hospital was referred to the Veterinary Medical Teaching Hospital, Jeju National University. Physical examination revealed abdominal distention. Blood analysis revealed hypoglycemia (57 mg/dL; reference range, 60-110 mg/dL). On abdominal ultrasonography, a heterogeneously hyperechoic mass measuring 7.51 × 10.6 cm was found at the level of the left kidney. Computed tomographic findings showed a unilateral left kidney mass with a 10-cm diameter and vessel contrast enhancement in the corticomedullary phase. Unilateral nephrectomy and ovariohysterectomy were performed because left ovary enlargement was observed during surgery. The renal mass was adjacent to the aorta and vena cava and attached to a portion of the small intestine, greater omentum, and left ovary. The mass was huge (12.5 × 10 × 7 cm) and was 16.5% of the body weight. Histopathological examination revealed renal cell carcinoma (RCC) and ovarian metastasis. After surgery, clinical signs improved remarkably, and serum glucose level returned to normal. As RCC is resistant to radiation and chemotherapy, the owner decided not to proceed with postoperative adjunctive therapies. To the best of our knowledge, this is the first case report of ovarian metastasis with huge RCC in a dog.

점액성 세관 방추세포 신장암종의 압착도말 세포소견 - 1예 보고 - (Mucinous Tubular and Spindle Cell Carcinoma of the Kidney: Touch Imprint Cytologic and Histologic Findings - A Case Report -)

  • 원규연;김교영;임성직;김현철;전승현
    • 대한세포병리학회지
    • /
    • 제19권2호
    • /
    • pp.194-199
    • /
    • 2008
  • The recent WHO classification has recognized mucinous tubular and spindle cell carcinoma (MTSCC) as a distinct entity of renal cell carcinoma, exhibiting a mixed pattern of tubules and a surrounding spindle cell proliferation within a myxoid stroma, with low-grade nuclear features. A 51-year-old woman had an incidentally discovered renal mass. Radiologic examination revealed a large, well defined mass in the lower pole of the right kidney; a right radical nephrectomy was performed. Imprint cytologic smears from fresh surgical specimens showed cellular, cohesive clusters with thick, broad trabecular arrangements and branching structures. On high power fields, the tumor was composed of round-to-oval low-grade nuclei with vesicular chromatin and small nucleoli. The tumor cells had indistinct borders and pale, eosinophilic cytoplasm, In some areas, round-to-elongated tubular structures and spindle cell patterns were noted. Chronic inflammatory cell infiltration was noted, along with a mucinous back-ground and occasional psammoma bodies. Neither significant cytologic atypia nor mitosis was seen.

Risk Factors for Renal Cell Carcinoma in a Japanese Population

  • Washio, Masakazu;Mori, Mitsuru;Mikami, Kazuya;Miki, Tsuneharu;Watanabe, Yoshiyuki;Nakao, Masahiro;Kubo, Tatsuhiko;Suzuki, Koji;Ozasa, Kotaro;Wakai, Kenji;Tamakoshi, Akiko
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권21호
    • /
    • pp.9065-9070
    • /
    • 2014
  • The incidence of renal cell carcinoma (RCC) is high in Western and Northern Europe and North America, and low in Asia. Although the incidence of RCC in Japan is lower than the rates in the other industrialized countries, there is no doubt that it is increasing. In this paper, we would like to introduce the summary of findings of JACC study, which evaluate the risk factors for RCC in a Japanese population. JACC study suggests nine risk factors (i.e., smoking, obesity, low physical activity, hypertension, diabetes mellitus, kidney diseases, beef, fondness for fatty food and black tea) and one preventive factor (i.e., starchy roots such as taro, sweet potato and potato) in a Japanese population. In Japan, however, drinking black tea may be a surrogate for westernized dietary habits while eating starchy roots may be a surrogate for traditional Japanese dietary habits. Further studies may be needed to evaluate risk factors for RCC because the number of cases is small in our studies.

Identification of Protein Markers Specific for Papillary Renal Cell Carcinoma Using Imaging Mass Spectrometry

  • Na, Chan Hyun;Hong, Ji Hye;Kim, Wan Sup;Shanta, Selina Rahman;Bang, Joo Yong;Park, Dongmin;Kim, Hark Kyun;Kim, Kwang Pyo
    • Molecules and Cells
    • /
    • 제38권7호
    • /
    • pp.624-629
    • /
    • 2015
  • Since the emergence of proteomics methods, many proteins specific for renal cell carcinoma (RCC) have been identified. Despite their usefulness for the specific diagnosis of RCC, such proteins do not provide spatial information on the diseased tissue. Therefore, the identification of cancer-specific proteins that include information on their specific location is needed. Recently, matrix-assisted laser desorption ionization (MALDI) mass spectrometry (MS) based imaging mass spectrometry (IMS) has emerged as a new tool for the analysis of spatial distribution as well as identification of either proteins or small molecules in tissues. In this report, surgical tissue sections of papillary RCC were analyzed using MALDI-IMS. Statistical analysis revealed several discriminative cancer-specific m/z-species between normal and diseased tissues. Among these m/z-species, two particular proteins, S100A11 and ferritin light chain, which are specific for papillary RCC cancer regions, were successfully identified using LC-MS/MS following protein extraction from independent RCC samples. The expressions of S100A11 and ferritin light chain were further validated by immunohistochemistry of human tissues and tissue microarrays (TMAs) of RCC. In conclusion, MALDI-IMS followed by LC-MS/MS analysis in human tissue identified that S100A11 and ferritin light chain are differentially expressed proteins in papillary RCC cancer regions.

페키니즈견에서 신장세포암종 (Renal Cell Carcinoma in a Pekingese Dog)

  • 이기창;정주현;변예은;오선경;서은정;송경진;권오경;윤정희;최민철
    • 한국임상수의학회지
    • /
    • 제22권2호
    • /
    • pp.148-152
    • /
    • 2005
  • 5년령 페키니즈가 촉진가능한 복강종괴 때문에 서울대학교 부속동물병원에 내원하였다. 실험실 검사에서 특별한 이상은 없었다. 방사선 검사에서 경계가 분명한 좌측 복부중간에 종괴가 있고 복강내 장막선 손실, 후복강의 비정형성투명도, 그리고 방사선 불투과성 방광 결석 소견을 나타냈다. 복강초음파에서 좌측신장에 불규칙한 모양을 한 비균질성 실질종괴가 발견되었고 좌측대형신장종괴가 장간막, 소장, 비장, 췌장을 침습한 소견을 관찰하였다. 편측성 신장요관절제술을 실시하였다. 조직병리소견에서 신장세포암종으로 확진하였다. 수술후 다음날 환축은 폐사하였다. 비록 초음파검사로 종괴에 관한 진단적 정보를 알 수 있지만, 컴퓨터 단층촬영은 종괴의 특성에 관한 핵심 영상 소견을 나타낸다

Combined Genotype Analyses of Precursor miRNA-196a2 and -499a Variants with Hepatic and Renal Cancer Susceptibility- a Preliminary Study

  • Toraih, Eman A;Fawzy, Manal S;Elgazzaz, Mona G;Hussein, Mohammad H;Shehata, Rasha H;Daoud, Hisham G
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권7호
    • /
    • pp.3369-3375
    • /
    • 2016
  • MicroRNAs, a novel class of small non-coding RNAs, are key players in many cellular processes, including cell proliferation, differentiation, invasion and regeneration. Tissue and circulatory microRNAs could serve as useful clinical biomarkers and deregulated expression levels have been observed in various cancers. Gene variants may alter microRNA processing and maturation. Thus, we aimed to investigate the association of MIR-196a2 rs11614913 (C/T), MIR-499a rs3746444 (A/G) polymorphisms and their combination with cancer susceptibility in an Egyptian population. Sixty five renal cell carcinoma (RCC) and 60 hepatocellular carcinoma (HCC) patients and 150 controls were enrolled in the study. They were genotyped using real-time polymerase chain reaction technology. Both $miR-196a2^*T$ and $miR-499a*G$ were associated with RCC risk, but only $miR-196a^*T$ was associated with HCC development. Carriage of the homozygote combinations ($MIR196a2^*TT+MIR499a^*AA$) and ($MIR196a2^*CC+MIR499a^*GG$) was associated with 25 and 48 fold elevation of likelhood to develop RCC, respectively. The miR-196a2 SNP was also linked with larger tumor size in RCC and advanced tumor stage in HCC. miR-196a2 and miR-499a combined genotypes were associated with RCC and HCC. Further functional analysis of SNPs is required to confirm relationships between genotypes and phenotypes.

낮은악성가능성을 가진 다방성낭성신장생성물: 증례 보고와 문헌 고찰 (Multilocular Cystic Renal Neoplasm of Low Malignant Potential: A Case Report and Literature Review)

  • 이지현;김동원;송주연;윤성국
    • 대한영상의학회지
    • /
    • 제83권1호
    • /
    • pp.173-177
    • /
    • 2022
  • 낮은악성가능성을 가진 다방성낭성신장생성물은 신종양 중 비교적 드문 타입으로 비교적 좋은 예후를 보인다. 이 종양은 주로 다방성의 신낭종으로 관찰되며 출혈을 동반한 복합신낭종으로 보이는 경우는 흔치 않다. 본 연구에서는 낮은악성가능성을 가진 다방성낭성신장생성물 증례를 보고하고 논문을 고찰하고자 한다.

사망이 확인되었던 폐암환지의 임상적 고찰 (Clinical Evaluation of Lung Cancer Confirmed to be Dead in the Post-operative Follow-up Periods)

  • 이두연
    • Journal of Chest Surgery
    • /
    • 제25권1호
    • /
    • pp.86-95
    • /
    • 1992
  • We have performed surgical operations for 184 primary lung carcinomas over a 10 year period from December, 1979 to December, 1990 at the department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea. We have reviewed 77 cases confirmed to be dead in the post-operative follow-up period among 184 cases. There were 68 males and 9 females [M: F=7.56: 1], with 76.62% ranging between 50 to 70 years old There were 50 cases[64.94%] of squamous cell carcinoma, 15[19.48%] of adenocarcinoma, 4[5.19%] of large cell carcinoma, 4[5.19%] of mixed cell carcinoma 3 [3.90%] of small cell carcinoma % 1 case of bronchoalveolar cell carcinoma. There were 25 cases[32.47%] in stage I, 12 [15.58%] in stage II 32 [41.56%] in stage IIIa and 8 [10.39%] in stage IIIb according to the new international staging system for lung cancer. The operative methods were left pneumonectomy in 38 cases, right pneumonectomy in 21, bilobectomy in 5, lobectomy in 12, and wedge resection in one case.ase. There were 9 operative mortalities; one case by bleeding, 5 cases by respiratory failure, one case by bleeding & renal failure, one case by empyema thoracis with BPF and one case by brain metastases. The actuarial mean survival length was 14.636$\pm$18.188months overall and 16.441$\pm$18. 627months in 68 cases excluding 9 operative deaths. The actuarial mean survival length was 18.568$\pm$11.057 months in 43 squamous cell carcinomas, 14.385$\pm$11.057 months in 14 adenocarcinomas, 10.250$\pm$8.884months in 4 large cell carcinomas and 12.250$\pm$17.193months in 4 mixed cell carcinomas. The actuarial mean survival length was 14.051$\pm$16.963months in 59 pneumonectomy cases, 15.200$\pm$12.478 months in 5 bilobectomy cases, 18.417$\pm$26.026months in 12 lobectomy cases. The actuarial mean survival length was 28.952$\pm$25.738months in 22 stage I cases, 19. 455$\pm$16.723months in ll stage II cases, 8.633$\pm$6.584months in 29 stage IIIa cases and 6. 167$\pm$4.355months in 6 stage IIIb cases. The differences of actuarial mean survival length according to the stages were statistically significant [a=0.003]

  • PDF

Tyrosine Kinase Inhibitor as Clinical Application Feasibility in Canine Intractable Tumor Diseases

  • Choi, Eul-Soo;Song, Joong-Hyun;Shin, Jong-Il;Sur, Jung-Hyang;Kang, Byeong-Teck;An, Su-Jin;Cho, Kyu-Woan;Jung, Dong-In
    • 한국임상수의학회지
    • /
    • 제33권4호
    • /
    • pp.187-193
    • /
    • 2016
  • A tyrosine kinase is an enzyme that can transfer a phosphate group from ATP to a protein in a cell. It functions as an "on" or "off" switch in many cellular functions. This study aims to show that the actions of growth factors associated with PDGFR-${\alpha}$, PDGFR-${\beta}$, VEGFR-2, c-KIT, and c-ABL, which are used in veterinary medicine, are expressed in canine intractable tumors. This study used archival cases of canine paraganglioma, gastrointestinal adenocarcinoma, hepatocellular carcinoma, and renal cell carcinoma. Tissues had been immunohistochemical analysis. The antibodies used were PDGFR-${\alpha}$, PDGFR-${\beta}$, c-kit, VEGFR-2, and c-Abl. PDGFR-${\alpha}$ was expressed only in HCC, and PDGFR-${\beta}$ was expressed in all tumors. VEGFR was also only expressed in HCC, and c-KIT has been expressed in HCC, paraganglioma, and small intestinal adenocarcinoma. c-Abl was expressed in all cancers, but was weakly expressed in paraganglioma, while more than moderately expressed in other tissues. In conclusion, this study investigated how TKIs used in human medicine can be applied to canine intractable tumors, through immunohistochemistry. The results indicate that there may be an application for TKIs in treating canine intractable tumors.